Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
2020 ◽
Vol 61
(4)
◽
pp. 636-646
◽
Terence J. O’Brien
◽
Simon Borghs
◽
Qin (Jane) He
◽
Anne‐Liv Schulz
◽
Stephen Yates
◽
...
2019 ◽
Vol 16
(11)
◽
pp. 1827-1833
Francesco Chierigo
◽
Paolo Capogrosso
◽
Federico Dehò
◽
Edoardo Pozzi
◽
Nicolò Schifano
◽
...
2005 ◽
Vol 8
(6)
◽
pp. A85-A86
J Young
◽
K Lheritier
◽
M Steel
◽
P Dwyer
2020 ◽
Vol 203
(3)
◽
pp. 448-448
2005 ◽
Vol 173
(4S)
◽
pp. 7-7
Caner Dinlenc
◽
Adam Berman
◽
Joseph Wagner
Harold Baxter
◽
Edward Carter
◽
Kelsi Marris
◽
Rachael Nugent
◽
Edward Weaver
2017 ◽
Vol 26
(6)
◽
pp. 1635-1645
◽
Lionne D. F. Venderbos
◽
Shafak Aluwini
◽
Monique J. Roobol
◽
Leonard P. Bokhorst
◽
Eric H. G. M. Oomens
◽
...
2018 ◽
Vol 118
◽
pp. e974-e981
◽
Michael L. Kelly
◽
Berje Shammassian
◽
Mary Jo Roach
◽
Charles Thomas
◽
Amy K. Wagner
2020 ◽
Vol 19
◽
pp. e1628-e1629
J. Jaipuria
◽
A. Singh
◽
S. Gupta
◽
S. Rawal
2019 ◽
Vol 156
(6)
◽
pp. S-1487
Noah Switzer
◽
Carla Holcomb
◽
Kayla Diaz
◽
Andrew Suzo
◽
Kyle A. Perry
Close
Export Citation Format
Close
Share Document
Close